图书馆主页
数据库简介
最新动态
联系我们



返回首页


 刊名字顺( Alphabetical List of Journals):

  A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL


  检 索:         高级检索

期刊名称:TRANSLATIONAL LUNG CANCER RESEARCH

ISSN:2218-6751
出版频率:Bi-monthly
出版社:AME PUBL CO, FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, PEOPLES R CHINA, HONG KONG, 00000
  出版社网址:http://www.amegroups.com
期刊网址:http://tlcr.amegroups.com
影响因子:6.498
主题范畴:ONCOLOGY;    RESPIRATORY SYSTEM;    China Journals
变更情况:Newly Added by 2019

期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)   



About the journal

Aims and Scope

Translational Lung Cancer Research (TLCR, Transl Lung Cancer Res, Print ISSN 2218-6751; Online ISSN 2226-4477) is an international, peer-reviewed, open-access journal, which was founded in March 2012. TLCR is indexed by Science Citation Index Expanded (SCIE), PubMed/PubMed Central, Scopus and the Chemical Abstracts Service (CAS) Databases. It is published quarterly the first year, and published bimonthly since February 2013. It provides practical up-to-date information on prevention, early detection, diagnosis, and treatment of lung cancer and related thoracic diseases. Specific areas of its interest include, but not limited to, multimodality therapy, markers, imaging, tumor biology, pathology, chemoprevention, and technical advances related to lung cancer and relevant thoracic diseases.

TLCR is dedicated to focus on cutting-edge developments at the transition from preclinical to clinical research and thus closes the gap between “bench and bedside”. The aim of TLCR is to provide a forum for the dissemination of original research and review articles in all areas related to lung cancer, as well as a timely platform for the exchange of key opinions between leading experts, and so to provide readers with a novel, well-organized, informative, enlightening and educational journal.

TLCR features a distinguished editorial board, which brings together a team of highly experienced specialists in lung cancer. The diverse experience of the board members allows our editorial panel to lend their expertise to a broad spectrum of lung cancer subjects. The entire submission and review process are managed through the OJS system, an electronic journal system which offers an efficient way and ensures a rapid turnaround of papers submitted for publication. Articles can be published both online and in print when necessary. See more at Information for Authors.


TLCR is endorsed by:

•    Spanish Lung Cancer Group(SLCG);
•    
Bonnie J. Addario Lung Cancer Foundation (ALCF);
•    
Brazilian Society of Thoracic Surgery (SBCT)

TLCR is the Official Publication of:

•    General Hospital of Eastern Theater Command, Nanjing, China
•   
 Society for Translational Medicine (STM), Hong Kong

Information for Authors

TLCR is a member of the International Committee of Medical Journal Editors (ICMJE) and follows the ICMJE recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journal and the Committee on Publication Ethics (COPE)'s guidelines.

Manuscripts submitted must be the original work of the author(s) and must not be published previously or under consideration for publication elsewhere.

Manuscripts Turnaround Time

  • In-house review: 1-3 weeks
  • External peer review: 1-3 months
  • Publication Ahead of Print: within 1 month after being accepted
  • Formal publication: within 1-3 months after being accepted. Original Articles are listed as priority.

Open Access Statement

This journal is a peer reviewed, open access journal. All content of the journal is published under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). All articles published open access will be immediately and permanently free for all to read, download, copy and distribute as defined by the applied license.

Free access and usage
Permitted third party reuse is defined by the CC BY-NC-ND 4.0 license. This license allows users to copy and distribute the article, provided:

  • this is not done for commercial purposes and further does not permit distribution of the Article if it is changed or edited in any way.
  • the user gives appropriate credit (with a link to the formal publication through the relevant DOI) and provides a link to the license but not in an any way implying that the licensor is endorsing the user or the use of the work.
  • no derivatives including remix, transform, or build upon the material was allowed for distribution.

The full details of the license are available at https://creativecommons.org/licenses/by-nc-nd/4.0/

Copyright

For open access publishing, this journal uses an exclusive licensing agreement. Authors will transfer copyright to TLCR, but will have the right to share their article in the same way permitted to third parties under the relevant user license, as well as certain scholarly usage rights.

For any inquiry/special circumstance on the copyright, commercial usage or adaptation of TLCR articles, please contact: permissions@amegroups.com

For reprint order, please contact: sales@amegroups.com

Editorial Office

Email: editor@tlcr.org 
Phone: +86 20 66355775

Publisher Information

TLCR is published by AME Publishing Company.
Address: Flat/RM C 16F, Kings Wing Plaza 1, NO. 3 on Kwan Street, Shatin, NT, Hong Kong, China.

 

Updated on April 03, 2020


Instructions to Authors

Indexing


Editorial Board

Honorary Editors-in-Chief

Fred R. Hirsch, MD, PhD

Executive Director, Center for Thoracic Oncology, Tisch Cancer Institute at Mount Sinai, New York, NY, USA

Yi-Long Wu

Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China

Editors-in-Chief

Yong Song, MD, PhD

Department of Respiratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China

Caicun Zhou, MD, PhD

Department of Oncology, Shanghai Pulmonary Hospital, Affiliated to Tongji University School of Medicine, Shanghai, China

Rafael Rosell, MD, PhD

Director, Cancer Biology & Precision Medicine Program Catalan Institute of Oncology; Germans Trias i Pujol Health Sciences Institute and Hospital Badalona, Barcelona, Spain

Associate Editors-in-Chief

Wenhua Liang, MD (Oncology)

Thoracic oncology, the First Affiliated Hospital of Guangzhou Medical University, China State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou, China

Heather A. Wakelee, MD (Medical Oncology)

Department of Medical Oncology, Stanford Cancer Institute, Stanford, California, USA

Wenzhao Zhong, MD, PhD (Biomarker)

Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China

Tangfeng Lv, MD (Respiratory Medicine)

Department of Respiratory Medicine, Jinling Hospital, Medical School of Nanjing University, Nanjing 210002, China


 返回页首 


邮编:430072   地址:中国武汉珞珈山   电话:027-87682740   管理员Email:
Copyright © 2005-2006 武汉大学图书馆版权所有